de Leval L, Bisig B, Thielen C, Boniver J, Gaulard P. Molecular classification of T-cell lymphomas. Crit. Rev. Oncol. Hematol. 2009; 72; 125-143.
de Leval L, Rickman DS, Thielen C et al. The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T (T FH) cells. Blood 2007; 109; 4952-4963.
Linterman MA, Vinuesa CG. Signals that influence T follicular helper cell differentiation and function. Semin. Immunopathol. 2010; 32; 183-196.
Chesi M, Bergsagel PL, Shonukan OO et al. Frequent dysregulation of the c-maf proto-oncogene at 16q23 by translocation to an Ig locus in multiple myeloma. Blood 1998; 91; 4457-4463.
Morito N, Yoh K, Fujioka Y et al. Overexpression of c-Maf contributes to T-cell lymphoma in both mice and human. Cancer Res. 2006; 66; 812-819.
Murakami YI, Yatabe Y, Sakaguchi T et al. c-Maf expression in angioimmunoblastic T-cell lymphoma. Am. J. Surg. Pathol. 2007; 31; 1695-1702.
de Leval L, Gisselbrecht C, Gaulard P. Advances in the understanding and management of angioimmunoblastic T-cell lymphoma. Br. J. Haematol. 2010; 148; 673-689.
Dorfman DM, Brown JA, Shahsafaei A, Freeman GJ. Programmed death-1 (PD-1) is a marker of germinal center-associated T cells and angioimmunoblastic T-cell lymphoma. Am. J. Surg. Pathol. 2006; 30; 802-810.
Natkunam Y, Tedoldi S, Paterson JC et al. Characterization of c-Maf transcription factor in normal and neoplastic hematolymphoid tissue and its relevance in plasma cell neoplasia. Am. J. Clin. Pathol. 2009; 132; 361-371.
